Tony Tang
About Tony Tang
Tony Tang serves as the Director of Early Clinical Development and Safety at CytomX Therapeutics, a position he has held since 2018. He holds an MD from Fudan University and a Ph.D. in Molecular Microbiology and Immunology from the University of Southern California.
Work at CytomX Therapeutics
Tony Tang has served as the Director of Early Clinical Development and Safety at CytomX Therapeutics since 2018. In this role, he oversees the clinical development processes and ensures the safety of clinical trials. His work contributes to the advancement of innovative therapies within the biopharmaceutical sector.
Education and Expertise
Tony Tang earned his Doctor of Medicine (MD) degree from Fudan University. He furthered his education at the University of Southern California, where he completed a Ph.D. in Molecular Microbiology and Immunology. His academic background provides a strong foundation for his work in clinical development and safety in the biopharmaceutical industry.
Background
Tony Tang has a diverse educational background that includes extensive training in medicine and microbiology. His studies at Fudan University and the University of Southern California have equipped him with the necessary skills and knowledge to excel in his current role at CytomX Therapeutics.
Achievements
Since joining CytomX Therapeutics in 2018, Tony Tang has played a significant role in the early clinical development and safety of various therapeutic candidates. His leadership in clinical trials has contributed to the organization's mission of developing innovative cancer therapies.